IHH Healthcare - CGS-CIMB Research 2023-12-01: An All-Around Improvement In 3Q23

• IHH Healthcare (SGX:Q0F)'s revenue grew 26.8% y-o-y to RM5.83bn in 3Q23, bringing 9M23 revenue to RM15.6bn, ahead of expectations at 78.0%/80.1% of our/Bloomberg consensus’ FY23F estimates.

Core revenues recovered in 3Q23

• - Read this at SGinvestors.io -
• Bed occupancy rate (BOR) across the group of IHH Healthcare reached 70% in 3Q23, up from 67% in 2Q23. No BOR data was provided for each country.

Net loss of RM62.3m in 3Q23 due to FX

• - Read this at SGinvestors.io -
• The persistent hyperinflationary environment in Turkey also led to higher depreciation and amortisation as a result of the reindexation of its assets in Turkey.

IHH Healthcare's hospital and healthcare operational statistics at a glance

• Read more at SGinvestors.io.

Above is the excerpt from research report by CGS-CIMB.
Clients of CGS-CIMB may access the full report in PDF @ https://www.itradecimb.com.sg/.

Read also CGS-CIMB's most recent report:
2023-12-02 IHH Healthcare - Scope For Better Profitability.

Price targets by 3 other brokers at IHH Healthcare Target Prices.

Listing of research reports at IHH Healthcare Analyst Reports.

Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividend Payout Dates & Corporate Actions,
IHH Healthcare News